Discontinued — last reported Q4 '19

Business Segments · Asset Impairment Charges

European Pharmaceutical Solutions — Asset Impairment Charges

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ2 2017
Last reportedQ4 2019

How to read this metric

Higher charges signal declining asset utility or an overly optimistic initial valuation of capital investments.

Detailed definition

This represents the total pre-tax charges recognized for the impairment of long-lived assets within the European Pharmac...

Peer comparison

Standard impairment reporting across global pharmaceutical and distribution companies.

Metric ID: mck_segment_european_pharmaceutical_solutions_asset_impairment_charges

Similar Metrics at Other Companies

Mondelez International logo
Mondelez InternationalMDLZView metric
Johnson & Johnson logo
Johnson & JohnsonJNJView metric
Mondelez International logo
Mondelez InternationalMDLZView metric
PepsiCo logo
PepsiCoPEPView metric
Eli Lilly logo
Eli LillyLLYView metric
PepsiCo logo
PepsiCoPEPView metric

Frequently Asked Questions

What does european pharmaceutical solutions — asset impairment charges mean?
The total pre-tax cost of reducing the recorded value of assets in the European segment due to loss of value.